Full Text View
Tabular View
No Study Results Posted
Related Studies
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer
This study is currently recruiting participants.
Study NCT00631527   Information provided by M.D. Anderson Cancer Center
First Received: February 27, 2008   Last Updated: May 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Leuprolide
Goserelin
Sunitinib Malate
Casodex
Radiation Therapy (RT)
Additional drug interventions recognized in this trial
Bicalutamide
Sunitinib
More general drug interventions related to this trial
Androgen Antagonists
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Fertility Agents
Fertility Agents, Female
Growth Inhibitors
Growth Substances
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services